Genetic Nondiscrimination in Canada

Canada’s parliament is set for a final vote on a proposed genetic nondiscrimination act.

Written byJoshua A. Krisch
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, SAFFRON BLAZECanada’s parliament threw its support behind bill S-201, legislation similar to the U.S. Genetic Information Nondiscrimination Act (GINA), which would fine insurers and employers for making decisions based on the results of genetic testing alone, according to The Hill Times. The bill passed a “third reading” on Wednesday night (March 8), the final chance for the House of Commons to debate its contents. The legislation will now return to the Senate for what many hope will be a final vote.

Under bill S-201, it would be illegal to force Canadian citizens to undergo genetic testing or provide results to insurance companies or employers. As with GINA, the main opposition is that the bill would be a blow to insurance companies and could raise premiums across the board, if insurers are required to assume more risk. Prime Minister Justin Trudeau has opposed the bill, telling reporters that “one of the elements in the proposed bill is unconstitutional,” according to Global News.

Specifically, some members of Trudeau’s Liberal Party believe the bill is an act of government overreach. They have proposed taking less drastic steps, such as amending the Canadian Human Rights Act to prohibit discrimination based on genetics in place of passing new legislation.

Advocates of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA